+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Analysis of BioMarin Pharmaceutical

1 of 4

FEATURED COMPANIES

  • Biogen Idec Inc
  • BioMarin Pharmaceutical
  • Enzon Pharmaceuticals Inc
  • MORE
BioMarin Pharmaceutical Inc. manufactures and markets biopharmaceuticals for many sever diseases and medical conditions. The company has many approved products along with several investigational product candidates. BioMarin markets its products to specialty pharmacies, pharmaceutical wholesalers in Europe, the US as well as Latin America. The company also retails through distributors and hospitals.

The Analysis of BioMarin Pharmaceutical. A complete and comprehensive analysis of BioMarin Pharmaceutical, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry, and then moves on to analyzing the company itself.

Company analysis includes a history of BioMarin Pharmaceutical, a business segment analysis of the segments BioMarin Pharmaceutical operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors.

A financial analysis of BioMarin Pharmaceutical is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.

A SWOT Framework Analysis of BioMarin Pharmaceutical completes this in-depth company analysis.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biogen Idec Inc
  • BioMarin Pharmaceutical
  • Enzon Pharmaceuticals Inc
  • MORE
A. Executive Summary

B. Looking at the Industry
B.1 Industry Definition
B.2 Brief Profile of the Industry
B.3 Impacts on the Industry
B.4 Challenges Facing the Industry
B.5 Future Perspective

C. Industry PEST Framework Analysis
C.1 Political Aspects
C.2 Economic Aspects
C.3 Social Aspects
C.4 Technological Aspects

D. Looking at BioMarin Pharmaceutical
D.1 Company Profile
D.2 History of the Company
D.3 Ownership Pattern in the Company
D.3.1 Major Holders
D.3.2 Major Direct Holders
D.3.3 Top Institutional Holders
D.3.4 Top Mutual Fund Holders
D.4 Organizational Divisions
D.5 Profiling the Key Executives
D.6 Products & Services

E. Looking at Business
E.1 Business Segments
E.2 Geographical Segments
E.3 Company Subsidiaries

F. BioMarin Pharmaceutical: SWOT Framework Analysis
F.1 Strengths to Build Upon
F.2 Weaknesses to Overcome
F.3 Opportunities to Exploit
F.4 Threats to Overcome

G. Profiling the Competition
G.1 BioSpecifics Technologies Corp
G.1.1 Corporate Profile
G.1.2 Business Segment Analysis
G.1.3 Financial Analysis
G.1.4 SWOT Analysis
G.2 Enzon Pharmaceuticals Inc
G.2.1 Corporate Profile
G.2.2 Business Segment Analysis
G.2.3 Financial Analysis
G.2.4 SWOT Analysis
G.3 Biogen Idec Inc
G.3.1 Corporate Profile
G.3.2 Business Segment Analysis
G.3.3 Financial Analysis
G.3.4 SWOT Analysis

H. BioMarin: Financial Analysis
H.1 Current Financials
H.2 Balance Sheet
H.3 Profit & Loss Statement
H.4 Ratio Analysis
H.4.1 Capital Market Ratios
H.4.2 Annual Ratios
H.4.3 Quarterly Ratios

I. BioMarin Pharmaceutical: Future Perspective

J. Glossary of Terms
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • BioSpecifics Technologies Corp
  • Enzon Pharmaceuticals Inc
  • Biogen Idec Inc
  • BioMarin Pharmaceutical
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll